Specifically, in metabolic diseases, researchers have found that plasma IL-38 increased in diabetes patients and was positively associated with markers of liver and kidney function, glucose metabolism, and serum lipids, which supported IL-38 as an associated factor of inflammation and/or altered metabolism [15, 19]. This evidence concerns the gene IL1F10 and Other metabolic disease.